...
首页> 外文期刊>Expert opinion on drug delivery >Multiple sclerosis patients treated with intramuscular IFN-beta-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction
【24h】

Multiple sclerosis patients treated with intramuscular IFN-beta-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction

机译:在现实环境中使用肌注IFN-β-1a自动注射器治疗的多发性硬化症患者:对治疗持续性,依从性,生活质量和满意度的前瞻性评估

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: The 12-month observational PERSIST study (NCT01405872) evaluated adherence associated with the intramuscular IFN beta-1a (i.m. IFN-beta-1a) autoinjector pen in multiple sclerosis (MS) patients.
机译:目的:为期12个月的观察性PERSIST研究(NCT01405872)评估了多发性硬化症(MS)患者与肌注IFNβ-1a(i.m. IFN-beta-1a)自动注射笔相关的依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号